The 10-second takeaway
For the quarter ended March 31 (Q1), Medidata Solutions beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased significantly. Non-GAAP earnings per share expanded significantly. GAAP earnings per share grew significantly.
Gross margins grew, operating margins contracted, net margins grew.
Medidata Solutions tallied revenue of $63.3 million. The seven analysts polled by S&P Capital IQ hoped for sales of $61.3 million on the same basis. GAAP reported sales were 26% higher than the prior-year quarter's $50.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.35. The eight earnings estimates compiled by S&P Capital IQ forecast $0.23 per share. Non-GAAP EPS of $0.35 for Q1 were 59% higher than the prior-year quarter's $0.22 per share. GAAP EPS of $0.22 for Q1 were 47% higher than the prior-year quarter's $0.15 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 72.9%, 190 basis points better than the prior-year quarter. Operating margin was 11.2%, 90 basis points worse than the prior-year quarter. Net margin was 9.0%, 150 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $65.3 million. On the bottom line, the average EPS estimate is $0.26.
Next year's average estimate for revenue is $267.2 million. The average EPS estimate is $1.12.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 52 members out of 60 rating the stock outperform, and eight members rating it underperform. Among 15 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 13 give Medidata Solutions a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Medidata Solutions is outperform, with an average price target of $59.67.
Is Medidata Solutions the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Medidata Solutions to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.